Latest News

Centeo Launches First Product

Centeo Biosciences has successfully launched its flagship product – the TG40 – a portable, temperature-controlled microtitre plate with docking station. TG40 is the first system designed specifically to enable optimization and screening of crystallization temperatures in a portable, hand-held device.

Wideblue worked in close collaboration with Centeo’s in-house scientific and engineering experts to develop the system concept into a market-ready product.

To create a tightly integrated electronic and thermal system in a user-friendly product format, development of the TG40 brought in the full range of Wideblue’s skills, from electronic, software, mechanical and optical design to establishing an international supply-chain and piloting the manufacturing process.

The first TG40 systems have been sold to pharmaceutical companies and academic institutions in Europe and the US.

Wideblue supports the John Logie Baird Awards for Innovation

We are once again supporting the John Logie Baird Innovation awards in 2009/10. Wideblue Project Manager Stuart Kelly sat on the Glasgow regional judging panel to assess a wide range of innovative business propositions. The winners will be announced at a gala dinner on 12th March 2010.

Wideblue Director presents a case study at the Life Sciences Scotland Med tech Forum

Wideblue Design and Development Director Grant King presented a case study that addressed some of the challenges in successfully taking a home healthcare product from initial idea to full commercialisation. The case study featured the Wideblue designed Breastlight, an award-winning product that assists in the early detection of breast cancer.

The Breastlight is a perfect example of how, with access to the right skills and funding, a product concept can be taken from an initial idea to widespread commercialisation in just over two years.

The Breastlight is now being sold in Boots stores throughout the UK, Rexall Pharmacies across Canada, and distributors in Germany, Finland, and Italy.

Wideblue founding partner in Kelvin Capital syndicate

Wideblue is a founding partner in newly established business angel syndicate Kelvin Capital, which has recently announced its first investment.

In association with the Boots Centre for Innovation, the syndicate will focus on innovative technologies in consumer healthcare and medical devices, as well as energy and renewables. Investment deal sizes will be between £50k and £2 million.

For details of how to access investment funding from Kelvin Capital, see the Kelvin Capital website.

Starting a business: What the over-50s need to know

Wideblue Managing Director Jim Hall is included in this Guardian article on starting a business, which draws on Jim’s experience of starting up Wideblue as a product design and development consultancy.

Read The Guardian article for more details.